The expression of the follicle-stimulating hormone receptor in spermatogenesis

被引:55
作者
Heckert, LL
Griswold, MD
机构
[1] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA
[2] Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA
来源
RECENT PROGRESS IN HORMONE RESEARCH, VOL 57 | 2002年 / 57卷
关键词
D O I
10.1210/rp.57.1.129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Results from experiments using mouse models suggest that the role of follicle-stimulating hormone (FSH) in spermatogenesis is the regulation of Sertoli cell proliferation and, ultimately, the size and spermatogenic capacity of the testis. The regulation of the expression of the FSH receptor (FSHR) gene is very cell specific and plays an initial role in the ultimate response of the Sertoli cells to FSH. The extreme cell specificity and the importance of the FSH response to spermatogenesis have led to an extensive characterization of the promoter of the FSHR gene. Several widely expressed transcription factors - including USF 1 and 2, GATA-1, and SF-1 and potential elements such as an E2F site and an Inr region - have been shown to contribute to the maximal transcription of the transfected FSHR gene. However, these experiments have failed to provide clues as to the cell-specific expression of the FSHR gene. In both cell transfections and in transgenic mice, the promoter can direct expression of transgenes promiscuously. The rodent FSHR promoter contains conserved CpG dinucleotides that were shown to be methylated in nonexpressing cells and tissue but unmethylated in Sertoli cells. The methylated CpG sites could interfere with the binding of general transcription factors and/or lead to a repressive chromatin structure in the nonexpressing cells. While yet-undiscovered cell-specific factors may play a role in the expression of the FSHR gene, repression and activation of local chromatin structure are likely to be involved.
引用
收藏
页码:129 / 148
页数:20
相关论文
共 86 条
[1]   The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction [J].
Abel, MH ;
Wootton, AN ;
Wilkins, V ;
Huhtaniemi, I ;
Knight, PG ;
Charlton, HM .
ENDOCRINOLOGY, 2000, 141 (05) :1795-1803
[2]   THYROTROPIN RECEPTOR PROCESSING AND INTERACTION WITH THYROTROPIN [J].
AKAMIZU, T ;
KOSUGI, S ;
KOHN, LD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (03) :947-952
[3]   The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph [J].
Asa, SL ;
Bamberger, AM ;
Cao, B ;
Wong, M ;
Parker, KL ;
Ezzat, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2165-2170
[4]   THE ORPHAN NUCLEAR RECEPTOR, STEROIDOGENIC FACTOR-I, REGULATES THE GLYCOPROTEIN HORMONE ALPHA-SUBUNIT GENE IN PITUITARY GONADOTROPES [J].
BARNHART, KM ;
MELLON, PL .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (07) :878-885
[5]   LOSS OF METHYLATION ACTIVATES XIST IN SOMATIC BUT NOT IN EMBRYONIC-CELLS [J].
BEARD, C ;
LI, E ;
JAENISCH, R .
GENES & DEVELOPMENT, 1995, 9 (19) :2325-2334
[6]  
Bender CM, 1998, CANCER RES, V58, P95
[7]   DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine [J].
Bovenzi, V ;
Lê, NLO ;
Cóté, S ;
Sinnett, D ;
Momparler, LF ;
Momparler, RL .
ANTI-CANCER DRUGS, 1999, 10 (05) :471-476
[8]   AMINO-TERMINAL LEUCINE-RICH REPEATS IN GONADOTROPIN RECEPTORS DETERMINE HORMONE SELECTIVITY [J].
BRAUN, T ;
SCHOFIELD, PR ;
SPRENGEL, R .
EMBO JOURNAL, 1991, 10 (07) :1885-1890
[9]   Steroidogenic factor 1 acts at all levels of the reproductive axis [J].
Caron, KM ;
Clark, BJ ;
Ikeda, Y ;
Parker, KL .
STEROIDS, 1997, 62 (01) :53-56
[10]   DEMONSTRATION OF AN FSH RECEPTOR IN A FUNCTIONING GRANULOSA-CELL TUMOR - EFFECT OF GONADOTROPIN TREATMENT ON ITS VIABILITY FOLLOWING TRANSPLANTATION TO NUDE MICE [J].
DAVY, M ;
TORJESEN, PA ;
AAKVAAG, A .
ACTA ENDOCRINOLOGICA, 1977, 85 (03) :615-623